HC Wainwright & Co. Reiterates Neutral on Co-Diagnostics, Maintains $3 Price Target

Co-Diagnostics, Inc.

Co-Diagnostics, Inc.

CODX

0.00

HC Wainwright & Co. analyst Yi Chen reiterates Co-Diagnostics (NASDAQ: CODX) with a Neutral and maintains $3 price target.